• 1
    Kariv I,Rourick R,Kassel D,Chung T. Improvement of “hit to lead” optimization by integration of in vitro HTS experimental models for early determination of pharmokinetic properties. Comb Chem High Throughput Screen 2002; 5: 459472.
  • 2
    Cox B,Denyer JC,Binnie A,Donnelly MC,Evans B,Green DV,Lewis JA,Mander TH,Merritt AT,Valler MJ,Watson SP. Application of high-throughput screening techniques to drug discovery. Prog Med Chem 2000; 37: 83133.
  • 3
    Davey HM,Kell DB. Flow cytometry and cell sorting of heterogeneous microbial populations: The importance of single-cell analyses. Microbiol Rev 1996; 60: 641696.
  • 4
    Herzenberg LA,Parks D,Sahaf B,Perez O,Roederer M,Herzenberg LA. The history and future of the fluorescence activated cell sorter and flow cytometry: A view from Stanford. Clin Chem 2002; 48: 18191827.
  • 5
    Li L,Darden D,Weinberg C,Levine A,Pederson L. Gene assessment and sample classification for gene expression data using a genetic algorithm/k-nearest neighbor method. Comb Chem High Throughput Screen 2001; 4: 727739.
  • 6
    Nagorsen D,Wang E,Panelli M. High-throughput genomics: An emerging tool in biology and immunology. Am Soc Histocompatibility Immunogenet 2003; 9698.
  • 7
    Chang C. The current novel high-throughput technology landscape. Drug Discov Dev 2004; 7: S14S17.
  • 8
    Stegmaier K,Ross KN,Colavito SA,O'Malley S,Stockwell BR,Golub TR. Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet 2004; 36: 257263.
  • 9
    Collins SJ,Ruscetti FW,Gallagher RE,Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 24582462.
  • 10
    Spradling A,Drummond-Barbosa D,Kai T. Stem cells find their niche. Nature 2001; 414: 98104.
  • 11
    Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999; 11: 634640.
  • 12
    Behonick DJ,Werb Z. A bit of give and take: The relationship between the extracellular matrix and the developing chondrocyte. Mech Dev 2003; 120: 13271336.
  • 13
    Kitano H. Systems biology: A brief overview. Science 2002; 295: 16621664.
  • 14
    Abbott A. Cell culture: Biology's new dimension. Nature 2003; 424: 870872.
  • 15
    Davidson EH,Rast JP,Oliveri P,Ransick A,Calestani C,Yuh CH,Minokawa T,Amore G,Hinman V,Arenas-Mena C,Otim O,Brown CT,Livi CB,Lee PY,Revilla R,Rust AG,Pan Z,Schilstra MJ,Clarke PJ,Arnone MI,Rowen L,Cameron RA,McClay DR,Hood L,Bolouri H. A genomic regulatory network for development. Science 2002; 295: 16691678.
  • 16
    Wolf K,Mazo I,Leung H,Engelke K,von Andrian UH,Deryugina EI,Strongin AY,Brocker EB,Friedl P. Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160: 267277.
  • 17
    Borisy AA,Elliott PJ,Hurst NW,Lee MS,Lehar J,Price ER,Serbedzija G,Zimmermann GR,Foley MA,Stockwell BR,Keith CT. Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci USA 2003; 100: 79777982.
  • 18
    van der Pouw Kraan TC,Kasperkovitz PV,Verbeet N,Verweij CL. Genomics in the immune system. Clin Immunol 2004; 111: 175185.
  • 19
    Hertzberg RP,Pope AJ. High-throughput screening: New technology for the 21st century. Curr Opin Chem Biol 2000; 4: 445451.
  • 20
    Edwards BS,Oprea T,Prossnitz ER,Sklar LA. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 2004; 8: 392398.
  • 21
    Irish JM,Hovland R,Krutzik PO,Perez OD,Bruserud O,Gjertsen BT,Nolan GP. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118: 217228.
  • 22
    Perez OD,Nolan GP. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 2002; 20: 155162.
  • 23
    Sachs K,Perez O,Pe'er D,Lauffenburger DA,Nolan GP. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005; 308: 523529.
  • 24
    Duda R,Hart P. Pattern Classification and Scene Analysis. New York: Wiley; 1973.
  • 25
    Eisen MB,Spellman PT,Brown PO,Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 1486314868.
  • 26
    Collins SJ. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 1987; 70: 12331244.
  • 27
    Trayner ID,Bustorff T,Etches AE,Mufti GJ,Foss Y,Farzaneh F. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leuk Res 1998; 22: 537547.
  • 28
    Collins SJ,Ruscetti FW,Gallagher RE,Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 1979; 149: 969974.
  • 29
    Fischkoff SA,Pollak A,Gleich GJ,Testa JR,Misawa S,Reber TJ. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med 1984; 160: 179196.
  • 30
    Hutt-Taylor SR,Harnish D,Richardson M,Ishizaka T,Denburg JA. Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60. Blood 1988; 71: 209215.
  • 31
    McCarthy DM,San Miguel JF,Freake HC,Green PM,Zola H,Catovsky D,Goldman JM. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res 1983; 7: 5155.
  • 32
    Rovera G,Santoli D,Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 1979; 76: 27792783.
  • 33
    Brown G,Bunce CM,Rowlands DC,Williams GR. All-trans retinoic acid and 1 α,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia 1994; 8: 806815.
  • 34
    Bunce CM,Wallington LA,Harrison P,Williams GR,Brown G. Treatment of HL60 cells with various combinations of retinoids and 1 α,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia 1995; 9: 410418.
  • 35
    Kang SN,Chung SW,Kim TS. Capsaicin potentiates 1,25-dihydoxyvitamin D3- and all-trans retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Eur J Pharmacol 2001; 420: 8390.
  • 36
    Tanaka H,Abe E,Miyaura C,Kuribayashi T,Konno K,Nishii Y,Suda T. 1 α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J 1982; 204: 713719.
  • 37
    Tsuda T,Wong D,Dolovich J,Bienenstock J,Marshall J,Denburg JA. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 1991; 77: 971979.
  • 38
    Verlinden L,Verstuyf A,Mathieu C,Tan BK,Bouillon R. Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-β2 and their combinations. J Steroid Biochem Mol Biol 1997; 60: 8797.
  • 39
    Wallington LA,Bunce CM,Durham J,Brown G. Particular combinations of signals, by retinoic acid and 1 α, 25 dihydroxyvitamin D3, promote apoptosis of HL60 cells. Leukemia 1995; 9: 11851190.
  • 40
    Zheng X,Chang RL,Cui XX,Kelly KA,Shih WJ,Lin Y,Strair R,Suh J,Han ZT,Rabson A,Conney AH. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1α,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Oncol Res 2000; 12: 419427.
  • 41
    Breitman TR,Selonick SE,Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 29362940.
  • 42
    Altieri DC,Edgington TS. A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 1988; 141: 26562660.
  • 43
    Goyert SM,Ferrero E,Rettig WJ,Yenamandra AK,Obata F,Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497500.
  • 44
    Sakai K,Hattori T,Sagawa K,Yokoyama M,Takatsuki K. Biochemical and functional characterization of MCS-2 antigen (CD13) on myeloid leukemic cells and polymorphonuclear leukocytes. Cancer Res 1987; 47: 55725576.
  • 45
    Watt SM,Sala-Newby G,Hoang T,Gilmore DJ,Grunert F,Nagel G,Murdoch SJ,Tchilian E,Lennox ES,Waldmann H. CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules. Blood 1991; 78: 6374.
  • 46
    Ketley NJ,Allen PD,Kelsey SM,Newland AC. Mechanisms of resistance to apoptosis in human AML blasts: The role of differentiation-induced perturbations of cell-cycle checkpoints. Leukemia 2000; 14: 620628.
  • 47
    Marekova M,Vavrova J,Vokurkova D. Dose dependent biological effects of idarubicin in HL-60 cells: Alterations of the cell-cycle and apoptosis. Acta Medica (Hradec Kralove) 2000; 43: 6973.
  • 48
    Matsuhisa T,Mori Y. Mode of differentiation of human promyelocytic leukemia cell line, HL-60, by 1 α,25-dihydroxyvitamin D3. Blood Cells Mol Dis 1995; 21: 4248.
  • 49
    Miyaura C,Abe E,Kuribayashi T,Tanaka H,Konno K,Nishii Y,Suda T. 1 α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 1981; 102: 937943.
  • 50
    Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002; 91: 877887.
  • 51
    Lelievre S,Weaver VM,Bissell MJ. Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: A model of gene regulation. Recent Prog Horm Res 1996; 51: 417432.
  • 52
    Garcia AM,Black AC,Gray ML. Effects of physicochemical factors on the growth of mandibular condyles in vitro. Calcif Tissue Int 1994; 54: 499504.
  • 53
    Saltzman WM. Principles in Tissue Engineering. San Diego: Academic Press; 2000 pp 221235.
  • 54
    Knuth E. The Art of Computer Programming. Reading, MA: Addison-Wesley; 1998. pp 4552.
  • 55
    Semb H. Human embryonic stem cells: Origin, properties and applications. APMIS 2005; 113: 743750.
  • 56
    Lundell BI,Vredenburgh JJ,Tyer C,DeSombre K,Smith AK. Ex vivo expansion of bone marrow from breast cancer patients: Reduction in tumor cell content through passive purging. Bone Marrow Transplant 1998; 22: 153159.
  • 57
    Williams SF,Lee WJ,Bender JG,Zimmerman T,Swinney P,Blake M,Carreon J,Schilling M,Smith S,Williams DE,Oldham F,Van Epps D. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 16871691.
  • 58
    Zanstra P,Eaves C,Piret J. Environmental requirements of hematopoietic progeneitor cells in ex vivo expansion systems. In: SchindhelmK, NordanR, editors. Ex Vivo Cell Therapy. San Diego: Academic Press; 1999. pp 246264.